Akamatsu, H., Mori, K., Naito, T., Imai, H., Ono, A., Shukuya, T., . . . Yamamoto, N. (2014). Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy. BioMed Central.
Chicago Style aipamenaAkamatsu, Hiroaki, et al. Progression-free Survival At 2 Years Is a Reliable Surrogate Marker for the 5-year Survival Rate in Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy. BioMed Central, 2014.
MLA aipamenaAkamatsu, Hiroaki, et al. Progression-free Survival At 2 Years Is a Reliable Surrogate Marker for the 5-year Survival Rate in Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy. BioMed Central, 2014.